Nomura Holdings
DCPH

Nomura Holdings’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Nomura Holdings’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-62,374
Closed -$609K – 2521
2021
Q4 		$609K Buy
+62,374
New +$1.17M ﹤0.01% 1393
2021
Q2 		– Sell
-20,500
Closed -$920K – 2394
2021
Q1 		$920K Buy
+20,500
New +$954K ﹤0.01% 1129

Other funds holding DCPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nomura Holdings's DCPH Position: Q1 2022 in Review

Nomura Holdings sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 62,374 shares — an estimated $609K sold.

Nomura Holdings first reported a position in DCPH in Q1 2021 and held it in 2 quarters. The position peaked at $920K in Q1 2021. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

  • Nomura Holdings reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Nomura Holdings sold 62,374 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $609K.
  • Nomura Holdings first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Nomura Holdings's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $920K in Q1 2021.
  • 123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.